Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to mani...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yan-Ruide Li, Tyler Halladay, Lili Yang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-01-01
Edice:	Journal of Biomedical Science
Témata:	Immune evasion Cell-based immunotherapies (CBIs) Chimeric antigen receptor (CAR) CAR-engineered T (CAR-T) cell therapy Tumor microenvironment (TME) Immune checkpoint proteins
On-line přístup:	https://doi.org/10.1186/s12929-024-00998-8
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!